Market revenue in 2023 | USD 9.7 million |
Market revenue in 2030 | USD 20.2 million |
Growth rate | 11.1% (CAGR from 2023 to 2030) |
Largest segment | Product |
Fastest growing segment | Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Product, Services |
Key market players worldwide | Thermo Fisher Scientific Inc, STEMCELL Technologies, Merck KGaA, Lonza Group Ltd, PromoCell GmbH, Cyagen Biosciences, Stemedica Cell Technologies, Axol Bioscience, Celprogen, Cellcolabs, Visual Photonics Epitaxy |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mesenchymal stem cells market will help companies and investors design strategic landscapes.
Product was the largest segment with a revenue share of 79.38% in 2023. Horizon Databook has segmented the South Africa mesenchymal stem cells market based on product, services covering the revenue growth of each sub-segment from 2018 to 2030.
Human embryonic stem cell use and research are at a nascent stage in South Africa. Stem cell research in South Africa relies more on cultural and regional beliefs. Morality and beliefs surrounding the use of stem cells harvested from human embryos are restricting the use of stem cells in Africa.
Furthermore, stem cell research regulatory legislation exists in the country. However, the enforcement of these regulations is not strict and can be exploited by medical scientists involved in stem cell tourism. Thus, such unethical factors related to stem cell research can hamper growth of the mesenchymal stem cell market in the country.
However, the availability of institutes like the South African Stem Cell Institute focusing on stem cell therapy and stem cell-based research activities is expected to boost the demand for MSCs and their products in the country in the coming years.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa mesenchymal stem cells market , including forecasts for subscribers. This country databook contains high-level insights into South Africa mesenchymal stem cells market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account